These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36697690)

  • 21. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
    Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
    EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conserved L464 in p97 D1-D2 linker is critical for p97 cofactor regulated ATPase activity.
    Zhang X; Gui L; Li S; Nandi P; Columbres RC; Wong DE; Moen DR; Lin HJ; Chiu PL; Chou TF
    Biochem J; 2021 Sep; 478(17):3185-3204. PubMed ID: 34405853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and Function of the AAA+ ATPase p97, a Key Player in Protein Homeostasis.
    Hänzelmann P; Galgenmüller C; Schindelin H
    Subcell Biochem; 2019; 93():221-272. PubMed ID: 31939153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the Design of p97-targeting Small Molecules from Structural Studies on p97 Functional Mechanism.
    Sui X; Pan M; Li YM
    Curr Med Chem; 2020; 27(2):298-316. PubMed ID: 31584361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism.
    Bruderer RM; Brasseur C; Meyer HH
    J Biol Chem; 2004 Nov; 279(48):49609-16. PubMed ID: 15371428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between the AAA ATPase p97/VCP and a concealed UBX domain in the copper transporter ATP7A is associated with motor neuron degeneration.
    Yi L; Kaler SG
    J Biol Chem; 2018 May; 293(20):7606-7617. PubMed ID: 29599289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An intrinsically disordered motif regulates the interaction between the p47 adaptor and the p97 AAA+ ATPase.
    Conicella AE; Huang R; Ripstein ZA; Nguyen A; Wang E; Löhr T; Schuck P; Vendruscolo M; Rubinstein JL; Kay LE
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26226-26236. PubMed ID: 33028677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detailed structural insights into the p97-Npl4-Ufd1 interface.
    Isaacson RL; Pye VE; Simpson P; Meyer HH; Zhang X; Freemont PS; Matthews S
    J Biol Chem; 2007 Jul; 282(29):21361-9. PubMed ID: 17491009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into the interaction of human p97 N-terminal domain and SHP motif in Derlin-1 rhomboid pseudoprotease.
    Lim JJ; Lee Y; Yoon SY; Ly TT; Kang JY; Youn HS; An JY; Lee JG; Park KR; Kim TG; Yang JK; Jun Y; Eom SH
    FEBS Lett; 2016 Dec; 590(23):4402-4413. PubMed ID: 27714797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain.
    Chia WS; Chia DX; Rao F; Bar Nun S; Geifman Shochat S
    PLoS One; 2012; 7(12):e50490. PubMed ID: 23226521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.
    Her NG; Toth JI; Ma CT; Wei Y; Motamedchaboki K; Sergienko E; Petroski MD
    Cell Chem Biol; 2016 Apr; 23(4):517-28. PubMed ID: 27105284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A threonine turnstile defines a dynamic amphiphilic binding motif in the AAA ATPase p97 allosteric binding site.
    Burnett JC; Lim C; Peyser BD; Samankumara LP; Kovaliov M; Colombo R; Bulfer SL; LaPorte MG; Hermone AR; McGrath CF; Arkin MR; Gussio R; Huryn DM; Wipf P
    Org Biomol Chem; 2017 May; 15(19):4096-4114. PubMed ID: 28352916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adapted ATPase domain communication overcomes the cytotoxicity of p97 inhibitors.
    Wei Y; Toth JI; Blanco GA; Bobkov AA; Petroski MD
    J Biol Chem; 2018 Dec; 293(52):20169-20180. PubMed ID: 30381397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation.
    Caffrey B; Zhu X; Berezuk A; Tuttle K; Chittori S; Subramaniam S
    J Biol Chem; 2021 Oct; 297(4):101187. PubMed ID: 34520757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of human FAF1 UBX domain reveals a novel FcisP touch-turn motif in p97/VCP-binding region.
    Kang W; Yang JK
    Biochem Biophys Res Commun; 2011 Apr; 407(3):531-4. PubMed ID: 21414298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase.
    Baron Y; Pedrioli PG; Tyagi K; Johnson C; Wood NT; Fountaine D; Wightman M; Alexandru G
    BMC Biol; 2014 May; 12():39. PubMed ID: 24885147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosensor-based small molecule fragment screening with biolayer interferometry.
    Wartchow CA; Podlaski F; Li S; Rowan K; Zhang X; Mark D; Huang KS
    J Comput Aided Mol Des; 2011 Jul; 25(7):669-76. PubMed ID: 21660516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward an understanding of the Cdc48/p97 ATPase.
    Bodnar N; Rapoport T
    F1000Res; 2017; 6():1318. PubMed ID: 28815021
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.